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ABSTRACT		In	the	present	work	RP-HPLC	method	has	been	developed	for	the	quantitative	estimation	of	Terbinafine	hydrochloride	in	bulk	drug	and	pharmaceutical	formulations.A	rapid	and	sensitive	RP-HPLC	Method	with	PDA	detection	(220	nm)	for	routine	analysis	of	in	Bulk	drug	and	Pharmaceutical	formulation	was	developed.	Chromatography	was	performed	with	mobile	phase	containing	a	mixture	of	Potassium	dihydrogen	phos-phate	and	Acetonitrile	(65:35	v/v)	with	flow	rate	1.5	ml/min.	The	linearity	was	found	to	be	in	the	range	of	50-150	µg/ml	with	(r2=0.999).	The	proposed	method	was	validated	by	determining	sensitivity,	accuracy,	precision,	LOD,	LOQ	and	system	suitability	parameters	according	to	ICH	guidrelines.	
Keywords:	Reverse	phase	high	pressure	liquid	chromatography	(RP-HPLC);	Terbinafine	Hydrochloride;	International	Conference	on	Harmonisation(ICH);	Photodiode	array(PDA)	detection.	
INTRODUCTION	Terbinafine	hydrochloride	 (Lamisil)[1]	 is	a	 synthetic	allylamine	 derivative	 and	 is	 hypothesized	 to	 act	 by	inhibiting	 squalene	 monooxygenase,	 thus	 blocking	the	 biosynthesis	 of	 ergosterol,	 an	 essential	component	of	fungal	cell	membranes.	This	inhibition	also	results	in	an	accumulation	of	squalene,	which	is	a	 substrate	 catalyzed	 to	 2,3-oxydo	 squalene	 by	
squalene	 monooxygenase[2].	 The	 resultant	 high	concentration	of	squalene	and	decreased	amount	of	ergosterol	 are	 both	 thought	 to	 contribute	 to	terbinafine's	antifungal	activity.	Terbinafine	is	active	against	 dermatophytes.	 Chemically	 it	 is[(2E)-6,6-dimethylhept-2-en-4-yn-1-yl](methyl)(naphthalen-1-ylmethyl)amine	 hydrochloride	 having	 molecular	formula	 C21H26CIN	 HCl	 and	 molecular	 weight	326.9299.	 It	 is	 white	 to	 off-white	 fine	 crystalline	powder	 It	 is	 freely	 soluble	 in	 methanol	 and	dichloromethane,	 freely	 soluble	 in	 anhydrous	ethanol,	soluble	in	ethanol,	slightly	and	very	slightly	soluble	 in	 water,	 and	 slightly	 soluble	 in	 acetone.	Literature	 survey[3-5]	 reveals	 that	 Terbinafine	hydrochloride	 can	 be	 estimated	 by	spectrophotometrically	 by	 HPTLC	 and	 by	 HPLC	individually	 with	 other	 drugs	 in	 bulk	 drugs	 and	 in	human	 plasma.	 Investigations	 of	 some	 new	instrumental	methods	are	in	need	for	the	quantitative	estimation	of	Terbinafine	Hydrochloride	in	bulk	drug	and	 its	 pharmaceutical	 dosage	 forms	 with	 high	sensitivity,	accuracy,	precision	and	economic	too.	
	
Figure	1:	Structure	of	Terbinafine	hydrochloride	
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MATERIALS	AND	METHODS		
Chemicals	 and	 reagents:	 Acetonitrile,	 Ortho	phosphoric	 acid,	 Potassium	 dihydrogenphospate,	Milli-Q	water	 All	 the	 chemicals	 used	were	 of	 HPLC	grade	 procured	 from	 qualigens	 Mumbai,	 S.D.	 Fine	Chem	 Ltd,	 Merck	 and	 Spectrochem,	Mumbai,	 India.	Methanol	was	used	for	making	the	solutions.	
Instruments:	 A	 gradient	 high	 pressure	 liquid	chromatograph	(Waters	–	Separation	Module	e	2695)	with	 one	 LC-10	 AT	 VP	 pumps,	 PDA	 detector	 2998,	Reverse	Phase	C-18	Column	(50	mm	x	4.6	i.d.,	particle	size	5	µm)	was	used	The	HPLC	system	was	equipped	with	the	EMPOWER	2	software.	
Drug	 sample:	 Standard	 Terbinafine	 hydrochloride	was	obtained	as	a	gift	sample	from	Hetero	Pvt.	Ltd.,	Hyderabad,	India.	
Marketed	 formulations:	 (Lamisil-150	 mg	 tablets)	from	Cipla	Pvt.	Ltd.,	Delhi,	 India	was	collected	 from	local	market.	
Chromatographic	Conditions	Column	:	INERTSIL	ODS	50×4.6mm5µm	Wavelength	 :	220nm	(UV	detector)	Temperature	 :	250c	Flow	rate	 :	1.5ml/min	Injection	volume	:	10µl	Mobile	phase	 	:	 Potassium	 dihydrogenphosphate:	acetonitrile	(65:35)	Run	time	 :	10	minutes	Prior	to	injection	of	the	drug	solution	the	column	was	equilibrated	for	at	least	30	min	with	the	mobile	phase	flowing	through	the	system.	The	datas	were	acquired,	stored	 and	 analyzed	 with	 the	 software	 class	EMPOWER2	(WATERS-2695).	The	chromatogram	obtained	through	the	injection	of	the	placebo	solution	did	not	contain	any	peak	at	the	retention	 time	 of	 Terbinafine	 hydrochloride.	 The	chromatogram	peak	purity	tools	show	that	the	peak	was	100%.	
Preparation	 of	 Standard	 Stock	 Solution	 of	
Terbinafine	 hydrochloride:	 50	mg	 of	 Terbinafine	hydrochloride	standard	was	accurately	weighed	and	transferred	to	a	100	ml	volumetric	flask,	dissolved	in	35	 ml	 of	 mobile	 phase	 and	 diluted	 to	 100ml	 with	mobile	phase	then	sonicated	for	10	min.	From	this	a	standard	solution[6]	100	µg/ml	was	prepared.	10	µl	of	standard	solution	was	injected	into	the	column	with	a	flow	rate	of	1.5	ml/min.	
Preparation	 of	 Standard	 working	 solutions	
(100%	 solution):	 From	 the	 above	 each	 stock	solution[7],	 1	 ml	 was	 pipetted	 out	 in	 to	 a	 10ml	volumetric	flask	and	then	make	up	to	the	final	volume	with	diluent.	
Preparation	of	Sample	stock	solutions:	20	tablets	were	 weighed,	 crushed,	 powdered	 and	 	 then	 the	tablet	 powder	 weight	 equivalent	 to	 10mg	 of	Terbinafine	was	transferred	into	a	100ml	volumetric	flask,	75ml	of	diluent	added	and	sonicate	for	30	min,	further	the	volume	made	up	with	diluent	and	filtered	through	0.45	μm	nylon	membrane.			
Preparation	of	Sample	working	solutions	(100%	
solution):	 From	 the	 filtered	 solution	 1ml	 was	pipetted	out	into	a	10	ml	volumetric	flask	and	made	upto	10ml	with	diluent.			
Buffer	Preparation:	Transfer	1.35gms	of	Potassium	dihydrogen	 phosphate	 into	 1000ml	 of	 beaker	 and	dissolve	 with	 water.	 Make	 up	 the	 volume	 with	water.Adjust	pH	3	with	Ortho	phosphoric	acid.	
Mobile	phase	preparation:	Transfer	buffer	solution	650ml	 and	 350ml	 of	 acetonitrile.	 Mix	 well	 and	sonicate	for	30minutes.	
RESULTS	After	 several	 trials	with	different	 combinations	and	ratio	 of	 solvents,	 the	 mobile	 phase	 potassium	dihydrogenphosphate	 :	 acetonitrile	 (65:35)	 was	selected,	because	it	was	found	that	it	ideally	resolve	the	peaks	with	retention	time	 [8]	(Rt)	of	Terbinafine	Hcl	 is	 6.2mins	 and	 the	 same	 is	 shown	 in	 Figure	 2.	Wavelength	 was	 selected	 by	 scanning	 all	 standard	drugs	over	a	wide	range	of	wavelength	200nm	to	400	nm.	
METHOD	VALIDATION	Validation[9]	of	an	analytical	method	is	the	process	to	establish	by	laboratory	studies	that	the	performance	characteristic	of	the	method	meets	the	requirements	for	 the	 intended	 for	 analytical	 application.The	present	 study	 was	 carried	 method	 was	 validated	based	on	ICH	(Q2B)	parameters	[10,11].	The	 following	 parameters	 were	 validated	 for	 the	proposed	method.	
Specificity	The	 specificity	 of	 the	 method	 was	 evaluated	 with	regard	 to	 interference	due	 to	presence	of	any	other	excipients.	 The	 figure	 shows	 that	 drug	 was	 clearly	separated	from	its	excipients.	Thus,	the	HPLC	method	presented	in	this	study	is	selective.	
Determination:	Volume	of	10µl	of	working	placebo	sample	solution	was	injected	into	the	chromatograph	and	the	chromatogram	was	recorded	and	presented	in	the	Figure	3.	
Linearity	and	range	The	 calibration	 curve	 was	 plotted	 with	 five	concentrations	of	the	standard	drug	solution	50-150	µg/ml	 and	 chromatography	was	 repeated	 six	 times	for	each	dilution.	The	linearity	was	evaluated	by		
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linear	regression	analysis.	Before	injecting	solutions,	the	column	was	equilibrated	for	at	least	30	min	with	the	mobile	 phase	 flowing	 through	 the	 system.	 Five	determinations	 were	 carried	 out	 for	 each	 solution,	peak	 areas	were	 recorded	 for	 all	 the	 solutions.	The	correlation	 graph	 was	 constructed	 by	 plotting	 the	peak	 areas	 obtained	 at	 the	 optimum	wavelength	 of	detection	v/s	the	injected	amounts	of	the	respective	concentrations.	
By	 using	 the	 working	 standard,	 aliquots	 of	 50,	 75,	100,	 125	 and	 150	 µg/ml	 were	 prepared	 with	acetonitrile	 six	 dilutions	 of	 each	 of	 the	 above	mentioned	concentrations	were	prepared	separately	and	 from	 these	 six	 dilutions,	 10	 µl	 of	 each	concentration	was	injected	into	the	HPLC	system	and	their	 chromatograms	 were	 recorded.	 Peak	 areas	were	recorded	for	all	the	peaks	and	a	standard		
 
Figure 2: Chromatogram of Terbinafine Hcl 
 
Figure 3: Chromatogram of placebo 
 
Figure 4: Chromatogram of Sample solution 
Table 1: Linearity data for Terbinafine hydrochloride 
Sl.No Concentration(µg/ml) Area 
1 0 0 
2 50 4749950 
3 75 7107990 
4 100 9578950 
5 125 11848700 
6 150 14279650 
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calibration	curve	of	peak	area	against	concentration	was	plotted.	
	
Precision	The	precision	of	the	assay	was	determined	in	terms	of	intra	and	inter-day	variation	in	the	peak	area	for	a	
Table	2:	Statistical	Data	for	Precision	
 Precision Mean  
 Intra-day 99.68%   Inter-day 99.61%   
Table	3:	Repeatability	Data	for	Terbinafine	hydrochloride	
 0 50 75 100 125 150 
 0 4749000     
 0      
 0  7107279  11848700  
 0      
 0      
 0 4750520  9487993 11848700 14295643 
 0  1589.174 7049.704   
 0  0.022358    
Table	4:	Determination	of	Recovery	studies	of	Terbinafine	hydrochloride	
    % Recovery 
50% 
50 25 74.955  
50 25 75.097  
50 25 75.112  
100% 
50 50 100.45 100.45 
50 50 100.09 100.09 
50 50 100.04 100.04 
150% 
50 75 124.75  
50 75 125.62  
50 75 125.87  
Table	5:	Statistical	Data	for	Recovery	studies	
recovery  
    
100%    
150%    
Table	6:	LOD	and	LOQ	of	Terbinafine	Hcl	
S. No.   
1   
2   
Table	7:	Results	of	system	suitability	parameters	
Parameters Data obtained for Terbinafine 
Theoretical plates per column 4530 
Symmetry factor/ Tailing factor 0.8 
Table	8:	Assay	Results	of	Tablet	Formulation	
    % Obtained 
1 75 75.15 7124100 100.2 
2 75 75.3 7138320 100.4 
3 75 75.225 7131210 100.3 
4 75 75.15 7124100 100.2 
5 75 75.075 7116990 100.1 
6 75 75 7109880 100 
Table	9:	Statistical	Data	for	Tablet	Formulation	
Components Mean  %RSD 
Terbinafine 100.2 0.141421 0.001411 
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set	of	drug	solution	(100	µg/ml)	assayed	 five	 times	on	the	same	day	and	on	three	different	days.The	intra	and	inter	day	variation	in	the	peak	ratio	of	the	drug	solution	 was	 calculated	 in	 terms	 of	 co-efficient	 of	variation	(CV)	and	obtained	by	multiplying	the	ratio	of	 standard	 deviation	 to	 the	 mean	 with	100(CV=SD/MEAN	X	100)	
Accuracy	The	 procedure	 for	 the	 preparation	 of	 solutions	 for	Accuracy	 determination	 at	 50%,	 100%	 and	 150%	level	 were	 prepared	 .	 The	 solutions	 were	 filtered	through	0.4	µm	membrane	filter	paper	and	then	they	were	subjected	to	analysis	by	RP-HPLC	method	under	the	 same	 chromatographic	 conditions	 as	 described	above.	 At	 each	 level,	 three	 determinations	 were	performed.	The	results	obtained	were	compared	with	expected	results	and	were	statistically	validated.	
Limit	 of	 Detection	 (LOD)	 and	 Limit	 of	
Quantitation	(LOQ)	LOD	 and	 LOQ	 were	 calculated	 according	 to	 ICH	recommendations	 where	 the	 approach	 is	 based	 on	the	 signal-to-noise	 ratio.	 Chromatogram	 signals	obtained	with	known	low	concentrations	of	analytes	was	 compared	with	 the	 signals	 of	 blank	 samples.	A	signal-to-noise	ratio	3:1	and	10:1	was	considered	for	calculating	LOD	and	LOQ	respectively.	The	values	of	LOD	and	LOQ	were	given	in	Table	6.	
System	Suitability	All	 the	 system	 suitability	 parameters	 are	 within	range	and	satisfactory	as	per	ICH	guidelines.	
DISCUSSION	According	 to	 ICH	 guidelines	 plate	 count	 should	 be	more	than	2000,	tailing	factor	should	be	less	than	2	and	resolution	must	be	more	than	2.	All	 the	system	suitable	parameters	were	within	the	limits.	
Assay	of	Terbinafine	hydrochloride	in	Tablets	Ten	 tablets	were	weighed	 and	 finely	 powdered.	 An	accurately	 weighed	 quantity	 of	 the	 powder	equivalent	 to	 100	mg	 of	 Terbinafine	 hydrochloride	was	transferred	to	100	ml	volumetric	flask	containing	40	ml	of	mobile	phase	and	the	contents	of	 the	 flask	were	 sonicated	 for	 15	min,	 to	 ensure	 the	 complete	solubility	of	the	drug,	then	the	mixture	was	made	up	to	100	ml	with	mobile	phase.The	 resulting	 solution	was	thoroughly	mixed	and	filtered	through	a	0.45	µm	membrane	 filter.	 From	 this	 a	 working	 standard	solution	 of	 100	 µg/ml	 of	 strength	 was	 prepared.	concentration	of	10µg/ml	were	prepared	 in	100	ml	volumetric	 flask	 &	 diluted	 with	 acetonitrile.	 This	concentration	(10	µl)	was	injected	six	times	into	the	column.	 The	 mean	 values	 of	 peak	 areas	 were	calculated	 and	 the	 drug	 content	 in	 the	 tablets	 was	quantified.	
	
	
CONCLUSION	In	 the	 present	 investigation,	 we	 have	 developed	 a	simple,	 sensitive,	 precise,	 accurate,	 rapid	 and	economical	 	 RP-HPLC	 method	 for	 the	 quantitative	estimation	 of	 Terbinafine	 Hcl	 in	 bulk	 drug	 and	pharmaceutical	 formulations.	 After	 development	 of	the	method,	 it	 was	 validated	 for	 system	 suitability,	specificity	and	linearity,	limit	of	detection	and	limit	of	quantification,	 precision	 and	 accuracyThe	 results	obtained	was	 found	 to	 be	within	 limits.	Hence,	 this	method	can	be	used	for	the	routine	determination	of	Terbinafine	Hcl	 in	bulk	drug	and	 in	pharmaceutical	formulations.	
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